These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Afterload reduction in the treatment of cardiac failure. Mason DT. Schweiz Med Wochenschr; 1978 Nov 04; 108(44):1695-703. PubMed ID: 102028 [Abstract] [Full Text] [Related]
6. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)]. Mauri F, Gronda E, Bossi M, Rovelli F. G Ital Cardiol; 1980 Oct 03; 10(4):414-23. PubMed ID: 7439582 [No Abstract] [Full Text] [Related]
7. [Prazosin in refractory congestive heart failure]. Timio M, Gentili S, Pede S, Schiaroli M. Boll Soc Ital Cardiol; 1978 Oct 03; 23(4):768-76. PubMed ID: 757362 [No Abstract] [Full Text] [Related]
8. [Comparative hemodynamic effect of sodium nitroprusside and prazosin hydrochloride in patients with cardiac insufficiency following acute myocardial infarction]. López-Sendón J, Coma Canella I. Rev Esp Cardiol; 1981 Oct 03; 34(1):55-61. PubMed ID: 7280350 [No Abstract] [Full Text] [Related]
9. Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure. Armstrong PW. Can Med Assoc J; 1979 Oct 06; 121(7):913-8. PubMed ID: 497982 [Abstract] [Full Text] [Related]
10. Vasodilator therapy of chronic congestive heart failure. Cabaniss CD. J Med Assoc Ga; 1980 Feb 06; 69(2):131-2. PubMed ID: 7373170 [No Abstract] [Full Text] [Related]
11. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year]. Reifart N, Schmidt-Moritz AD, Nadj M, Kaltenbach M, Bussmann WD. Z Kardiol; 1985 Apr 06; 74(4):205-12. PubMed ID: 3923726 [Abstract] [Full Text] [Related]
12. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure. Elkayam U, Mathur M, Frishman W, LeJemtel T, Strom J, Sonnenblick EH. Clin Pharmacol Ther; 1981 Jul 06; 30(1):23-30. PubMed ID: 7237894 [Abstract] [Full Text] [Related]
13. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure. Mason DT. Am J Med; 1978 Jul 06; 65(1):106-25. PubMed ID: 99030 [Abstract] [Full Text] [Related]
14. Early and medium term results of tailored therapy for heart failure. Martins S, Soares RM, do Rosário L, Quininha J, Antunes AM. Rev Port Cardiol; 2001 Mar 06; 20(3):261-82. PubMed ID: 11417309 [Abstract] [Full Text] [Related]
15. Can prazosin be used in the treatment of refractory heart failure only on the basis of clinical monitoring? Nikolić V, Planinc D, Rudar M, Pagon L. Wien Med Wochenschr; 1987 Jan 15; 137(1):9-13. PubMed ID: 3590814 [Abstract] [Full Text] [Related]
16. New therapies in the management of congestive heart failure. Atkins FL. J Kans Med Soc; 1980 Feb 15; 81(2):83-5, 94. PubMed ID: 7351512 [No Abstract] [Full Text] [Related]
17. [Use of vasodilator agents in circulatory insufficienty]. Halawa B. Wiad Lek; 1979 Nov 15; 32(22):1617-20. PubMed ID: 120075 [No Abstract] [Full Text] [Related]
18. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)]. Yui Y, Nakajima H, Sakurai K, Wakabayashi A, Kawai C. Kokyu To Junkan; 1981 Jul 15; 29(7):723-6. PubMed ID: 7291740 [No Abstract] [Full Text] [Related]
19. [Treatment of chronic congestive failure with vasodilators (acute trial with prazosin and erythrityl tetranitrate)]. Tomov I, Kaloianova A, Terzieva L, Nikolov G, Elenkova A. Vutr Boles; 1982 Jul 15; 21(6):45-50. PubMed ID: 6761964 [Abstract] [Full Text] [Related]